Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalMarket CapitalizationNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Sunshine Biopharma (SBFM) Enterprise Value: 2010-2025

Historic Enterprise Value for Sunshine Biopharma (SBFM) over the last 13 years, with Sep 2025 value amounting to -$2.5 million.

  • Sunshine Biopharma's Enterprise Value rose 69.71% to -$2.5 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$30.7 million, marking a year-over-year increase of 42.66%. This contributed to the annual value of -$3.7 million for FY2024, which is 60.44% up from last year.
  • Sunshine Biopharma's Enterprise Value amounted to -$2.5 million in Q3 2025, which was up 32.76% from -$3.7 million recorded in Q2 2025.
  • In the past 5 years, Sunshine Biopharma's Enterprise Value registered a high of $4.3 million during Q1 2022, and its lowest value of -$26.0 million during Q3 2022.
  • For the 3-year period, Sunshine Biopharma's Enterprise Value averaged around -$6.3 million, with its median value being -$4.4 million (2025).
  • Its Enterprise Value has fluctuated over the past 5 years, first crashed by 9,706.42% in 2021, then spiked by 337.41% in 2022.
  • Over the past 5 years, Sunshine Biopharma's Enterprise Value (Quarterly) stood at -$2.1 million in 2021, then slumped by 259.10% to -$7.4 million in 2022, then decreased by 26.45% to -$9.3 million in 2023, then skyrocketed by 60.44% to -$3.7 million in 2024, then spiked by 69.71% to -$2.5 million in 2025.
  • Its Enterprise Value was -$2.5 million in Q3 2025, compared to -$3.7 million in Q2 2025 and -$4.4 million in Q1 2025.